Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections.
Davoud AfsharFarzaneh RafieeMozhgan KheirandishSolmaz Ohadian MoghadamMohammad AzarsaPublished in: Clinical and experimental vaccine research (2020)
The lytA protein seems to be a highly immunogenic antigen and a potential target for developing vaccines against pneumococcal infections.